BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.
FDA Recall Z-2023-2024 · Posted 2024-06-05
Advertisement
Recalling FirmBecton Dickinson & Co.
Recall StatusOpen, Classified
Product CodeQJR
Date Initiated2024-05-07
Product Quantity2,061 kits
Reason for Recall
Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.
Firm Action
Consignees were mailed and/or emailed an URGENT: Medical Device Product Correction notification, dated 5/7/24. The notification instructs consignees to immediately inspect their inventory for affected devices and destroy them per the consignee's destruction process, ensure the notification is read and understood, disseminate the notification to among those in your organization and customers who should be made aware, and return the completed Response Form to BD by email to [email protected] or by fax to 312-949-0438. Consignees with any complaints can call 1-844-823-5433 or email [email protected]; consignees with any recall related questions can email [email protected].
Root Cause
Component design/selection
Distribution Pattern
Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement